Medtronic Reports Results of PRODIGY Study in Patients with Opioid-Induced Respiratory Depression (OIRD)

 Medtronic Reports Results of PRODIGY Study in Patients with Opioid-Induced Respiratory Depression (OIRD)

Medtronic Reports Results of PRODIGY Study in Patients with Opioid-Induced Respiratory Depression (OIRD)

Shots:

  • The PRODIGY (Prediction of Opioid-induced respiratory Depression In patients monitored by capnography) study reports results of the PRODIGY score in 1,496 patients at high risk of developing respiratory compromise (OIRD)across 16 sites in the US, Europe and Asia
  • The PRODIGY study demonstrated 76% identification of patients with confirmed respiratory depression (AUC=0.7620), presented at Society of Critical Care Medicine’s (SCCM) 48th Critical Care Congres
  • PRODIGY OIRD risk prediction tool is used to identify patients at the risk of OIRD and guide early intervention using continuous capnography-based monitoring to improve patient safety

Click here to read full press release/ article | Ref: Medtronic | Image: Twitter

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post